Quest Diagnostics Inc
(NYSE:DGX)
$
153.02
-0.4 (-0.26%)
Market Cap: 17.08 Bil
Enterprise Value: 23.40 Bil
PE Ratio: 20.57
PB Ratio: 2.52
GF Score: 86/100 Quest Diagnostics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 11, 2021 / 04:30PM GMT
Release Date Price:
$137.85
(-2.57%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
Hi, good afternoon, good morning, everybody. I'm Derik De Bruin, senior life sciences and diagnostic tools analyst for Bank of America. Welcome to our 2021 Virtual Viva Las Vegas Healthcare conference. Also with me from Bank of America is Ivy Ma who focuses on diagnostics companies also on the group. And so in diagnostics, we have Quest Diagnostics with us this morning for our next presenters. With us today is Mark Guinan, Executive Vice President and Chief Financial Officer; and Shawn Bevec, Head of IR. Gentlemen, welcome. Thanks for being here today.
Mark J. Guinan
Quest Diagnostics Incorporated - Executive VP & CFO
Thanks, Derik.
Shawn C. Bevec
Quest Diagnostics Incorporated - VP of Investor Relation
Thanks, Derik.
Questions & Answers
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
So, Mark, I want to start off with a big picture question just because
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot